Search Results 1451-1460 of 16306 for alt

  1. A Study to Evaluate Hepcidin Mimetic in Patients With Polycythemia Vera - Mayo Clinic

    Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ≥ 2.5 × upper limit of normal (ULN) or direct bilirubin > 1.5 × ULN. Pregnant or ...

  2. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

    Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 ULN (≤ 5 × ULN for patients with liver metastases);; Albumin ≥ 2.8 g/dL. Renal.

  3. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

    Alanine transaminase (ALT) > 2.5 × upper limit of normal (ULN);; Total bilirubin > 1.5 × ULN (unless due to Gilbert's syndrome);; Platelet count < 75,000/μL ...

  4. CorMatrix ECM Tricuspid Valve Replacement - Mayo Clinic

    Documented evidence of intrinsic hepatic disease (defined as liver enzyme values (AST, ALT or total bilirubin) that are > 5 times the upper limit of ...

  5. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

    AST and ALT ≤ 2.5 × the ULN; bilirubin ≤ 1.5 × ULN (except subjects with Gilbert's Syndrome who may have bilirubin ≤ 3.0 × ULN following discussion with the ...

  6. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

    Liver function tests: bilirubin > 1.5 × the ULN for age (with the exception of those with Gilbert syndrome) or AST/ALT > 2 × upper limit of normal. Renal ...

  7. Arimoclomol Prospective Study in Patients Diagnosed With NiemannPick Disease Type C - Mayo Clinic

    Severe liver insufficiency (defined as hepatic laboratory parameters, AST and/or ALT greater than three-times the upper limit of normal for age and gender ( ...

  8. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

    Elevation of aspartate aminotransferase (AST), alanine aminotransferase (ALT), or bilirubin \>2 × upper limit of normal (ULN) 3. Primary sclerosing ...

  9. Awards - Education Science and Scholarship - Resources for Schools - Academy of Educational Excellence

    Supporting the advancement of educational sciences through research grants, career development programs, and other activities that build a community of ...

  10. Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients - Mayo Clinic

    Hepatic transaminases (AST and ALT) ≤ 2x ULN within 14 days prior to randomization. Adequate renal function (serum creatinine ≤ 1.5x ULN) within 14 days ...